Dr. FANG Yong graduated from Jiangxi Medical College with a master's degree in July 1999 and a doctoral degree in oncology from Zhejiang University Medical School in June 2003. Since 2000, he has worked in the SRRSH Department of Medical Oncology. From 2012 to 2013, he served as a visiting scholar at New York University School of Medicine. He has engaged in medical oncology for nearly 20 years with rich clinical experience in tumor chemotherapy, molecular targeted therapy, immunity and minimally invasive therapy, especially minimally invasive ablation of lung cancer, biological immunity and individualized comprehensive therapy. He has published more than 20 papers related to cancer research and treatment in international SCI journals and national first-class journals and participated in the compilation of 3 monographs. He also took part in a number of global large-scale multi-center clinical studies of new anti-tumor drugs. He is a member of the Zhejiang common malignant tumor innovation team. Having authorized 1 national invention patent, he currently leads and participates in more than 10 national and provincial projects.

Deputy Chairman of the Radiofrequency Ablation Committee of the Chinese Society of Clinical Oncology (CSCO)

Standing Committee member of the Ablation Therapy Branch of the Minimally Invasive Cancer Treatment Professional Committee of the China Anti-Cancer Association (CACA)

Chairman of the Multi-Primary and Unknown Origin Tumor Professional Committee of the Zhejiang Anti-Cancer Association

Chair-designate of the Oncology Internal Medicine Professional Committee of the Zhejiang Anti-Cancer Association